Lincoln Pharmaceuticals Limited LINCOLN.NS
LINCOLN.NS
Lincoln Pharmaceuticals Limited WANBURY.NS
Wanbury Limited WANBURY.BO
Wanbury Limited THEMISMED.NS
Themis Medicare Limited THEMISMED.BO
Themis Medicare Limited SAKAR.NS
Sakar Healthcare Limited VENUSREM.NS
Venus Remedies Limited VENUSREM.BO
Venus Remedies Limited MAXIND.NS
Max India Limited INDSWFTLAB.BO
Ind-Swift Laboratories Limited
Lincoln Pharmaceuticals Limited WANBURY.NS
Wanbury Limited WANBURY.BO
Wanbury Limited THEMISMED.NS
Themis Medicare Limited THEMISMED.BO
Themis Medicare Limited SAKAR.NS
Sakar Healthcare Limited VENUSREM.NS
Venus Remedies Limited VENUSREM.BO
Venus Remedies Limited MAXIND.NS
Max India Limited INDSWFTLAB.BO
Ind-Swift Laboratories Limited
Performance
| Periode | LINCOLN.NS | WANBURY.NS | WANBURY.BO | THEMISMED.NS | THEMISMED.BO | SAKAR.NS | VENUSREM.NS | VENUSREM.BO | MAXIND.NS | INDSWFTLAB.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -15.35 % | -20.17 % | -20.23 % | -27.76 % | -27.82 % | 14.17 % | 37.80 % | 42.44 % | -16.17 % | 3.80 % |
| YTD | -0.08 % | -5.82 % | -5.53 % | -8.26 % | -7.97 % | -0.38 % | 0.16 % | 3.77 % | -7.36 % | 22.90 % |
| 1Y | -40.14 % | -9.76 % | -9.40 % | -65.19 % | -65.06 % | 39.15 % | 155.84 % | 161.99 % | -34.53 % | 2.22 % |
| 3Y | 41.21 % | 401.81 % | 87.24 % | -28.49 % | -27.93 % | 71.98 % | 349.28 % | 96.20 % | 76.68 % | 22.48 % |
| 5Y | 108.34 % | 294.77 % | 87.24 % | 172.24 % | 173.28 % | 612.39 % | 345.47 % | 96.20 % | 177.86 % | 22.48 % |
| 10Y | 167.45 % | 217.73 % | 87.24 % | 124.85 % | 131.42 % | 611.14 % | 685.31 % | 96.20 % | 123.75 % | 22.48 % |
| Depuis le début | 119.25 % | 57.48 % | 87.24 % | 613.80 % | 4 094.06 % | 611.14 % | 96.48 % | 96.20 % | 123.75 % | 22.48 % |